FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs — $7 billion in savings for patients
RedMap Risk Score
80/100
CRITICAL RISK
Risk Signal Summary
The FTC reached a settlement with Express Scripts, Inc. to resolve allegations of inflated insulin prices due to unfair practices. The settlement is expected to save patients up to $7 billion over 10 years and enhance transparency in drug pricing.
Why This Matters
Governance and compliance anomalies in organizations managing public funds or charitable assets directly affect donors, beneficiaries, and taxpayers. The risk indicators identified in this report warrant further scrutiny by regulators, donors, and oversight bodies.
Create a free account
Unlimited access to all articles · No daily limit
No credit card · Instant access
Multiple related entities detected
🔒 Express Scripts, Inc. has potential risk indicators with connected organizations. Unlock full network analysis.
Sign up free to unlock →Disclaimer: This report identifies risk indicators and unusual financial patterns based on publicly available IRS Form 990 data and government enforcement records. It does not assert fraud, criminal conduct, or legal violations. All findings are for informational purposes only and should not be construed as legal or financial advice.
Related Risk Signals
CorporateNew York Business Owner Sentenced to Prison for Laundering $1.5M in Health Care Fraud Proceeds
New York, NY
Michigan Home Health Care Agency Owner Convicted of $1.6M Medicare Fraud Scheme
Farmington Hills, MI
California AG Bonta Requests Information from FIFA on Ticketing Practices — Potential Violations of State Law
Oakland, CA
California Attorney General Arrests Fentanyl Trafficker — $1.3 Million in Drugs Seized
Arcadia, CA
Share this finding
You just analyzed Express Scripts, Inc. — Risk Score 80/100, $7.0B involved. Share this with your network.
Post text is pre-formatted for maximum reach — you can edit before posting.
Discover more risk signals across the USA.